Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.66 |
| ▸ | FFAR4 | Q5NUL3 | 10/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | SYK | P43405 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | AR | P10275 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20651276 | 0.84 | SMN1; SMN2 (0.63) | SMN1; SMN2FFAR4TDP1ALOX15TP53 | |
| SCHEMBL5958762 | 0.83 | SMN1; SMN2 (0.67) | SMN1; SMN2FFAR4TDP1ALOX15TP53 | |
| SCHEMBL2748456 | 0.82 | SMN1; SMN2 (0.52) | SMN1; SMN2FFAR4TDP1ALOX15TP53 | |
| SCHEMBL29441420 | 0.82 | SMN1; SMN2 (0.52) | SMN1; SMN2FFAR4TDP1ALOX15TP53 | |
| Hydrochloric Acid SCHEMBL27738830 | 0.80 | SMN1; SMN2 (0.50) | SMN1; SMN2FFAR4TDP1ALOX15TP53 | |
| SCHEMBL12352871 | 0.79 | SMN1; SMN2 (1.00) | SMN1; SMN2FFAR4TDP1ALOX15TP53 | |
| SCHEMBL5583842 | 0.79 | AR (0.60) | SMN1; SMN2FFAR4TDP1ALDH1A1POLB | |
| SCHEMBL28669112 | 0.79 | SMN1; SMN2 (0.57) | SMN1; SMN2FFAR4TDP1ALOX15TP53 | |
| SCHEMBL10216057 | 0.79 | SMN1; SMN2 (0.57) | SMN1; SMN2FFAR4TDP1ALOX15TP53 | |
| SCHEMBL4273522 | 0.78 | SMN1; SMN2 (0.45) | SMN1; SMN2FFAR4TDP1SYKAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025243317-A1 | SUBSTITUTED BICYCLIC SULFONAMIDE DERIVATIVES AS MODULATORS OF CBL-B | JUBILANT BIOSYS LIMITED (IN) | 2025-11-27 | — | — | WO | disclosed |
| CN-119930443-A | Method for synthesizing trifluoromethyl substituted aniline by using tetradentate platinum complex as photocatalyst | 九洲药业(杭州)有限公司 | 2025-05-06 | — | — | CN | disclosed |
| WO-2024061807-A1 | ORGANIC ELECTRONIC DEVICE COMPRISING A CHARGE GENERATION LAYER | NOVALED GMBH (DE) | 2024-03-28 | — | — | WO | disclosed |
| EP-4013500-B1 | TRICYCLIC AKR1C3 DEPENDENT KARS INHIBITORS | NOVARTIS AG (CH) | 2023-10-25 | — | — | EP | disclosed |
| EP-3686199-B9 | FUSED RING DERIVATIVE AS A2A RECEPTOR INHIBITOR | CSTONE PHARMACEUTICALS SUZHOU CO LTD (CN) | 2022-12-07 | — | — | EP | disclosed |
| US-11518766-B2 | Tricyclic compound, preparation method therefor and use thereof | SHANGHAI JEMINCARE PHARMACEUTICALS CO., LTD. (CN) | 2022-12-06 | — | — | US | disclosed |
| WO-2022228449-A1 | PREPARATION METHOD FOR POLYIMIDE RESIN AND THIN FILM THEREOF | 上海瑞暨新材料科技有限公司 | 2022-11-03 | — | — | WO | disclosed |
| EP-3998263-A1 | TRICYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | Shanghai Jemincare Pharmaceuticals Co., Ltd. (CN) | 2022-05-18 | — | — | EP | disclosed |
| US-20220024928-A1 | 3-(PHENYLSULFONYL)-[1,2,3]TRIAZOLO[1,5A]QUINAZOLIN-5(4H)-ONE DERIVATIVES | BioVersys AG (CH) | 2022-01-27 | — | — | US | disclosed |
| WO-2020163236-A1 | TREATING LONG QT SYNDROME | THE GENERAL HOSPITAL CORPORATION (US) | 2020-08-13 | — | — | WO | disclosed |
| US-20050038296-A1 | Organic electrolumescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2005-02-17 | — | — | US | disclosed |
| US-6743948-B1 | HAVING DUAL CHRYSENE RINGS LINKED BY AMINO FUNCTIONALITY HAVING FURTHER ARYL AND ALKENYL SUBSTITUTION; EFFICIENCY; HEAT RESISTANCE; DURABILITY | IDEMITSU KOSAN CO., LTD. (JP) | 2004-06-01 | — | — | US | disclosed |
| US-20030072966-A1 | Organic electrolumescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2003-04-17 | — | — | US | disclosed |
| WO-2002040445-A1 | GLUCAGON ANTAGONISTS/INVERSE AGONISTS | NOVO NORDISK A/S (DK) | 2002-05-23 | — | — | WO | disclosed |
| EP-1061112-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | IDEMITSU KOSAN COMPANY LIMITED (JP) | 2000-12-20 | — | — | EP | disclosed |
| US-4745219-A | Chemical intermediates and a process for their preparation | MONSANTO COMPANY (US) | 1988-05-17 | — | — | US | disclosed |
| US-4731450-A | Process for perfluoroalkylation of aromatic derivatives | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1988-03-15 | — | — | US | disclosed |
| EP-0084320-B1 | 4-ALKYL-2-TRIFLUOROMETHYL ANILINES | BAYER AG (DE) | 1985-08-28 | — | — | EP | disclosed |
| EP-0084320-A2 | 4-Alkyl-2-trifluoromethyl anilines | BAYER AG (DE) | 1983-07-27 | — | — | EP | disclosed |
| US-4059402-A | SUBLIMATION, MONOAZO DYES | BAYER AKTIENGESELLSCHAFT (DT) | 1977-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030072966-A1 | Organic electrolumescence device | ABCC1, CCND1, JUND | SMN1; SMN2 2346/4885FFAR4 3535/4885TDP1 1805/4885 |
| US-11518766-B2 | Tricyclic compound, preparation method therefor and use thereof | TFPI, TFPI2, F11 | SMN1; SMN2 3397/4885FFAR4 1085/4885TDP1 1661/4885 |
| US-20220024928-A1 | 3-(PHENYLSULFONYL)-[1,2,3]TRIAZOLO[1,5A]QUINAZOLIN-5(4H)-ONE DERIVATIVES | OR10J3, ORC3, CBR3 | SMN1; SMN2 2417/4885FFAR4 2997/4885TDP1 4273/4885 |
| US-20050038296-A1 | Organic electrolumescence device | CHRM1, SCO2, CHRM4 | SMN1; SMN2 2658/4885FFAR4 3758/4885TDP1 2609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.